Andrews Ronald Asbury's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Aug 18, 2022
- Accession no.
- 0001493152-22-023462
- Filed
- Aug 18, 2022
- Trade date
- Aug 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $38.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andrews Ronald AsburyCIK 0001299153 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Common Stock, no par value | PPurchaseAcquired | +40,000 | $0.96 | +$38,400 | 333,212 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.